ADIPOQ and fatty liver disease: Adiponectin action in preventing the development of fatty liver disease may also involve its direct effect in this tissue by suppressing the expression of SREBF1c, which upregulates the main enzymes involved in fatty acid synthesis (Awazawa et al., 2009).